glp 1 with dpp 4 PDB-101: Diabetes Mellitus: Diabetes Mellitus: undefined: DPP4 Glucagon-like peptide-1 - Wikipedia

Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of incretin-based therapies for the management of hyperglycemia and, in some cases, cardiovascular risk in people with type 2 diabetes

Special populations and considerations Different patient populations have different considerations when it comes to choosing between insulin and GLP-1 therapy

This review covers the development of multi-agonist therapies, including GLP-1glucagon and GIPGLP-1glucagon receptor agonists, which represent a significant advancement in obesity treatment

An adequate and unimpeded circulation system is a critical determinant for placental nutrient supply

Diabetes Care 43(5):10851093 Wilding JPH, Batterham RL, Calanna S et al (2021) Once-weekly semaglutide in adults with overweight or obesity